321 related articles for article (PubMed ID: 21613330)
21. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
22. Mannose-binding lectin gene: polymorphisms in Japanese patients with systemic lupus erythematosus, rheumatoid arthritis and Sjögren's syndrome.
Tsutsumi A; Sasaki K; Wakamiya N; Ichikawa K; Atsumi T; Ohtani K; Suzuki Y; Koike T; Sumida T
Genes Immun; 2001 Apr; 2(2):99-104. PubMed ID: 11393663
[TBL] [Abstract][Full Text] [Related]
23. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
24. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood CD5+ B cell subset in the remission phase of systemic connective tissue diseases.
Markeljević J; Batinić D; Uzarević B; Bozikov J; Cikes N; Babić-Naglić D; Horvat Z; Marusić M
J Rheumatol; 1994 Dec; 21(12):2225-30. PubMed ID: 7535356
[TBL] [Abstract][Full Text] [Related]
27. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
Du Y; Su Y; He J; Yang Y; Shi Y; Cui Y; Luo C; Wu X; Liu X; Hu F; Ma X; Zheng L; Zhang J; Zuo X; Sheng Y; Wu L; Zhang X; Guo J; Li Z
Ann Rheum Dis; 2015 Nov; 74(11):2070-5. PubMed ID: 24906639
[TBL] [Abstract][Full Text] [Related]
28. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism.
Correa PA; Gomez LM; Cadena J; Anaya JM
J Rheumatol; 2005 Feb; 32(2):219-24. PubMed ID: 15693080
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
30. Autoantibodies against alpha-fodrin in Sjögren's syndrome with neurological manifestations.
de Seze J; Dubucquoi S; Fauchais AL; Hachulla E; Matthias T; Lefranc D; Hatron PY; Vermersch P; Witte T
J Rheumatol; 2004 Mar; 31(3):500-3. PubMed ID: 14994394
[TBL] [Abstract][Full Text] [Related]
31. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
32. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS.
Sutcliffe N; Stoll T; Pyke S; Isenberg DA
J Rheumatol; 1998 Jan; 25(1):63-8. PubMed ID: 9458204
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
[TBL] [Abstract][Full Text] [Related]
34. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
[TBL] [Abstract][Full Text] [Related]
35. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
37. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.
Zhao M; Zhou Y; Zhu B; Wan M; Jiang T; Tan Q; Liu Y; Jiang J; Luo S; Tan Y; Wu H; Renauer P; Del Mar Ayala Gutiérrez M; Castillo Palma MJ; Ortega Castro R; Fernández-Roldán C; Raya E; Faria R; Carvalho C; Alarcón-Riquelme ME; Xiang Z; Chen J; Li F; Ling G; Zhao H; Liao X; Lin Y; Sawalha AH; Lu Q
Ann Rheum Dis; 2016 Nov; 75(11):1998-2006. PubMed ID: 26787370
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
[TBL] [Abstract][Full Text] [Related]
39. Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset.
Baer AN; Maynard JW; Shaikh F; Magder LS; Petri M
J Rheumatol; 2010 Jun; 37(6):1143-9. PubMed ID: 20360189
[TBL] [Abstract][Full Text] [Related]
40. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
